News Briefing channel feed – Endpoints News

News Briefing channel feed

More biotechs announce share buybacks; Cosette to buy Mayne Pharma

2 months ago

Illumina to lay off about 100 people; Incyte’s new AI partnership

2 months ago

Another Chinese biotech files to go public in Hong Kong; A new ROR1 ADC deal

2 months ago

Septerna ends Phase 1 trial for hypoparathyroidism drug; Sanofi’s Merilog is approved

2 months ago

Otsuka makes pipeline changes; Oculis reveals $100M offering

2 months ago

Allay Therapeutics raises $45M for ongoing Series D; Encoded’s layoffs

2 months ago

Biogen downplays capacity for M&A; Roche’s SMA drug is approved as a tablet

2 months ago

IN8bio’s Phase 1 AML data; Layoffs at Q32 Bio and Third Harmonic

2 months ago

Roivant discontinues lung disease drug; Bio-Thera, Intas make biosimilar deal

3 months ago

AffyImmune’s layoffs; Henlius makes a biosimilar deal with Dr. Reddy’s

3 months ago

Bristol Myers, Kyowa Kirin disclose layoffs

3 months ago

Turnstone stops TIL studies; GH Research’s $150M offering

3 months ago

Tectonic to raise $185M; Acelyrin drops rights to Affibody drug

3 months ago

Ironwood's layoffs; Shionogi’s RSV pill succeeds in Phase 2

3 months ago

Curie.Bio has a new $340M fund; Layoffs at Benchling, I-Mab

3 months ago

Akero, 89bio disclose public offerings; BioAge drops Phase 2 obesity drug

3 months ago

Allakos restructures after Phase 1 failure; AB2 inks deal with Nippon Shinyaku

3 months ago

Boehringer merges cancer vaccine and oncolytic virus teams; Dantari sells off assets

3 months ago

FDA delays decision on Stealth’s Barth syndrome drug; TargetRx raises $50M

3 months ago

Shanghai Bao, Sichuan Biokin file IPOs in Hong Kong; Disc's $200M offering

3 months ago

FDA puts Atara’s INDs on hold after rejection; Ascletis' safety data for obesity pill

3 months ago

WuXi AppTec sells medical device testing unit; Layoffs at Notch Therapeutics

3 months ago

Boehringer's schizophrenia asset fails Phase 3; GSK buys organoid biotech

3 months ago

Hinge Bio's $30M raise; Keros reports additional issues in Phase 2 PAH trial

3 months ago

First page Previous page 1 234 5 6 Next page Last page